Nine Point Two Capital LLC Castle Biosciences Inc Call Options Transaction History
Nine Point Two Capital LLC
- $252 Million
- Q4 2023
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CSTL
# of Institutions
162Shares Held
25.3MCall Options Held
82.2KPut Options Held
150K-
Black Rock Inc. New York, NY2.6MShares$45.2 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT2.55MShares$44.4 Million0.3% of portfolio
-
Granahan Investment Management, LLC Waltham, MA1.63MShares$28.3 Million1.3% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.53MShares$26.7 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.49MShares$26 Million0.0% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $458M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...